# AZD2066 Neuropathic Pain - Mechanical Hypersensitivity

> **NCT00939094** · PHASE2 · TERMINATED · sponsor: **AstraZeneca** · enrollment: 87 (actual)

## Conditions studied

- Neuropathic Pain
- Mechanical Hypersensitivity

## Interventions

- **DRUG:** AZD2066
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00939094
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-08
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2012-09-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00939094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00939094, "AZD2066 Neuropathic Pain - Mechanical Hypersensitivity". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00939094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*